Tietoja työnantajasta
BIOASTER is the only health-related Technology Research Institute (TRI) in France selected by the General Commission for Investments [Commissariat Général à l’Investissement] as part of its Investment for the Future [Programme des Investissements d’Avenir] program. The BIOASTER project is a joint initiative with Lyonbiopole (international competitiveness cluster) and Institut Pasteur. BIOASTER was established as a Foundation for Scientific Cooperation (FSC) based on an innovative public/private partnership model. It offers a novel approach to R&D based on integrating several scientific and technological disciplines. BIOASTER conducts independent and collaborative interdisciplinary R&D activities on the frontier between basic and industrial development to ensure optimal alignment between research and innovation in the fields of infection diseases and microbiology and expand our understanding of intestinal microbiota and its impact on health